Neusa Alves Da Silva Ustekinumab Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Ustekinumab from India and how much does Neusa Alves Da Silva import?

India exports Ustekinumab to 78 buyers globally worth $457.7K. Neusa Alves Da Silva imports $29.7K (2.3% market share) with 5 shipments from BRAZIL.

Q: What is the average order value for Neusa Alves Da Silva's Ustekinumab imports?

Neusa Alves Da Silva's average Ustekinumab order value is $5.9K per consignment, based on 5 shipments totaling $29.7K.

Q: Who supplies Ustekinumab to Neusa Alves Da Silva?

Top Indian Ustekinumab suppliers: NIVIRA EXPORTS ($299.9K), GNH INDIA PHARMACEUTICALS LIMITED ($240.5K), BIOCON BIOLOGICS INDIA LIMITED ($160.7K), VAMA LIFECARE PRIVATE LIMITED ($126.1K), R B INTERNATIONAL ($74.6K).

Q: Who are the top Ustekinumab importers from India?

Top Ustekinumab importers: AS PER INVOICE BRAZIL ($112.2K), SHIMA HIROMI ($100.0K), TO THE CONCERN PERSON ($56.2K), TO THE CONSIGNEE- ($46.6K), NEUSA ALVES DA SILVA ($29.7K).

Suresh Sormare

Ustekinumab

India Pharmaceutical Trade Intelligence

$1.3M23 Suppliers10 CountriesHS 30021500

ExportsIndia → BRAZIL71.5%India → JAPAN12.6%

ImportsNETHERLANDS → India$1.5M UNITED STATES → India$1.1M

#1 Supplier: NIVIRA EXPORTS #1 Buyer: AS PER

Neusa Alves Da Silva — Ustekinumab Importer #5 | $29.7K Trade Value | TransData Nexus | TransData Nexus

Neusa Alves Da Silva — Ustekinumab Importer Profile

Pharmaceutical Importer · #5 buyer for Ustekinumab · $29.7K import value · 5 shipments · BRAZIL · DGFT Verified

Neusa Alves Da Silva is the #5 importer of Ustekinumab from India with $29.7K in import value and 5 verified shipments. Neusa Alves Da Silva holds a 2.3% market share in Ustekinumab imports based in BRAZIL.

Neusa Alves Da Silva — Ustekinumab Import Profile: Suppliers, Formulations & Sources

Neusa Alves Da Silva — Ustekinumab import analysis from Indian Customs (DGFT) data.

Who Supplies Ustekinumab to Neusa Alves Da Silva?

Supplier	Value	Shipments	% Share
NIVIRA EXPORTS	$299.9K	61	1
GNH INDIA PHARMACEUTICALS LIMITED	$240.5K	33	1
BIOCON BIOLOGICS INDIA LIMITED	$160.7K	5	2
VAMA LIFECARE PRIVATE LIMITED	$126.1K	55	1

How Does Neusa Alves Da Silva Compare to Nearest Ustekinumab Importers?

Buyers ranked immediately above and below #5 by import value

#	Buyer	Country	Import Value	Shipments	Avg/Shipment
3	TO THE CONCERN PERSON	BRAZIL	$56.2K	9	$6.2K
4	TO THE CONSIGNEE-	SAUDI ARABIA	$46.6K	2	$23.3K
5	NEUSA ALVES DA SILVA ★	BRAZIL	$29.7K	5	$5.9K
6	ISIS DE OLIVEIRA MELO FELTRIN	BRAZIL	$24.1K	4	$6.0K
7	IMPORT MANAGER INTERNATIONAL SALES CO	TURKEY	$22.1K	3	$7.4K

Neusa Alves Da Silva ranks #5 among 78 Ustekinumab importers from India. Average shipment value of $5.9K compared to the market average of $5.9K. The closest competitors by value are TO THE CONCERN PERSON and TO THE CONSIGNEE-.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ustekinumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: Neusa Alves Da Silva matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as Neusa Alves Da Silva's capped import value divided by total capped export value for Ustekinumab across all Indian exporters.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 10+ countries, 78+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ustekinumab

Ustekinumab

Neusa Alves Da Silva — Ustekinumab Importer Profile

Neusa Alves Da Silva — Ustekinumab Import Profile: Suppliers, Formulations & Sources

Who Supplies Ustekinumab to Neusa Alves Da Silva?

How Does Neusa Alves Da Silva Compare to Nearest Ustekinumab Importers?

Regulatory Requirements: Importing Ustekinumab into Brazil

Regulatory Authority

Approval Process for Generic Ustekinumab

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Ustekinumab from India and How Much Does Neusa Alves Da Silva Import?

What Is the Average Order Value for Neusa Alves Da Silva's Ustekinumab Imports?

Who Supplies Ustekinumab to Neusa Alves Da Silva?

How Does Neusa Alves Da Silva Compare to Other Ustekinumab Importers?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ustekinumab Import Data for Neusa Alves Da Silva

Neusa Alves Da Silva × Ustekinumab

Related Analysis

Need Detailed Import Data?

Data Source